Estramustine phosphate sodium (C007B-152241)

Estramustine phosphate sodium (EMP, Emcyt, Estracyt) is an antitumour drug with a unique dual mode of action. Estrone and estradiol, products of the metabolism of estramustine phosphate sodium, have shown antigonadotrophic activity resulting in reduced testosterone levels. Estramustine(the cytotoxic metabolite produced by dephosphorylation of estramustine phosphate sodium) is an antiprostatic tumor drug with antimicrotubule effects. Specification: ≥95% Molecular Formula: C23H30Cl2NNa2O6P Molecular Weight: 564.35 PubChem CID: 444000 Isomeric SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OP(=O)([O-])[O-])CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl.[Na+].[Na+] Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/E275650-SCI_74cc426256818763e651def31a4bcc21.pdf

UPC:

51111803

Condition:

New

Weight:

0.97 Ounces

HazmatClass:

No;ManufacturerName=Aladdin Scientific"

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

E275650-250mg

CAS:

52205-73-9

Product Size:

250mg

Hazard Statement Codes:

H351:H361

Precautionary Statement Codes:

P201:P202:P280:P308+P313:P405:P501

Controlled Substances and Cyanide:

Yes